- Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
- Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease
- PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
Sept 30, 2020 | Clinical Trial
70. Doctors in Lowell Report Positive Outcomes for Second COVID-19 Patient Treated with Laser Therapy
Sept 29, 2020 | Clinical Trial
69. Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites
Sept 29, 2020 | Clinical Trial
68. Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19
Sept 28, 2020 | Clinical Trial
67. COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
Sept 28, 2020 | Clinical Trial
63. INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
Sept 28, 2020 | Regulatory
62. FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica’s itMSC Therapy for COVID-19 Patients
Sept 28, 2020 | Regulatory
61. Preventative Nasal Spray Shown to Reduce Viral Replication by up to 96% in COVID-19 Challenge Study
Sept 28, 2020 | Clinical Trial
60. Parade/Cleveland Clinic ‘Healthy Now’ Survey Reveals Positive Long-term Effects of COVID-19 Pandemic: Embracing Healthy Lifestyle Changes, Valuing Personal Relationships, Finding Meaning, Remaining Hopeful
Sept 25, 2020 | Clinical Trial
59. Novavax Initiates P-III Study of its COVID-19 Vaccine in the UK
Sept 25, 2020 | Clinical Trial
58. JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study
Sept 24, 2020 |
57. Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay from Abacus Diagnostica
Sept 23, 2020 | Diagnostic
56. J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine
Sept 24, 2020 | Clinical Trial
55. DURECT Corporation Announces First Patient Dosed in Phase 2 Safety and Efficacy Study of DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury
Sept 23, 2020 | Clinical Trial
54. Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Sept 23, 2020 | Collaboration
53. Avigan Shows Promising Results in Treatment of COVID Patients in Japan
Sept 23, 2020 | Clinical Trial
52. FDA Authorizes First Point-of-Care Antibody Test for COVID-19
Sept 23, 2020 | Diagnostic
51. DetectaChem Smartphone-Based COVID-19 Test Advances Through NIH RADx (Rapid Acceleration of Diagnostics) Program
Sept 22, 2020 | DigiHealth
50. FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
Sept 21, 2020 | Regulatory
49. Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device
Sept 21, 2020 | Collaboration
48. Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia
Sept 18, 2020 | Clinical Trial
47. Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies
Sept 18, 2020 | Diagnostic
46. Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies
Sept 18, 2020 | Collaboration
45. NRL, NCATS Scientists Develop Method to Safely Study COVID-19, Other Contagious Diseases
Sept 18, 2020 | Clinical Trial
44. Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial
Sept 18, 2020 | Clinical Trial
43. HSS Funds Innovative Research on COVID-19
Sept 18, 2020 | Grant
42. Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells
Sept 18, 2020 | Clinical Trial
41. Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Sept 17, 2020 | Clinical Trial
40. Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients
Sept 17, 2020 | Clinical Trial
39. CEBINA Reports Positive Findings on the Potency of Azelastine
Sept 17, 2020 | Clinical Trial
38. Seattle AVM Biotechnology Announces Second IND for AVM0703: Clinical Trial Permitted to Treat COVID-19 and Influenza ARDS with its ‘supercharged’ Version of Dexamethasone
Sept 16, 2020 | Regulatory
37. Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting
Sept 16, 2020 | Clinical Trial
36. Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance
Sept 15, 2020 | Clinical Trial
35. FUJIFILM Sonosite and the CHEST Foundation Partner for COVID-19 Research
Sept 15, 2020 | Collaboration
34. BenevolentAI’s Platform-Derived Hypothesis for COVID-19 Treatment Validated in US NIAID Randomised Control Trial
Sept 14, 2020 | Clinical Trial
33. Ampion Phase I COVID-19 Patient Trial Results Featured on FOX News
Sept 14, 2020 | Clinical Trial
32. Biotechnology Leader LuminUltra Submits COVID-19 Clinical Diagnostic Testing Kit for Regulatory Authorization in U.S., Canada
Sept 14, 2020 | Diagnostics
31. Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122
Sept 14, 2020 | Diagnostics
30. RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK
Sept 14, 2020 | Clinical Trial
29. Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
Sept 14, 2020 | Clinical Trial
28. Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine
Sept 14, 2020 | Collaboration
27. Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient Discharged Following Five Days of Treatment
Sept 11, 2020 | Regulatory
26. Pfizer and BioNTech to Supply 200M Doses of it COVID-19 Vaccine in the EU
Sept 10, 2020 | Collaboration
25. New Study Published in PLOS Medicine Explores Impact of Race, Age & Comorbidities on COVID-19 Mortality
Sept 10, 2020 | Clinical Trial
24. Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial
Sept 09, 2020 | Clinical Trial
23. Bioclinica Partners with Direct Biologics to Provide Interactive Response Technology (IRT) Solution for COVID-19 Study
Sept 09, 2020 | Clinical Trial
22. Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients
Sept 09, 2020 | Clinical Trial
21. The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
Sept 09, 2020 | Clinical Trial
20. New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims
Sept 09, 2020 | Diagnostics
19. DPHARM Presents the Largest Number of Sessions Across R&D on Decentralized Clinical Trials Due to COVID-19
Sept 09, 2020 | Clinical Trial
18. Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19
Sept 08, 2020 | Clinical Trial
17. Celularity Doses First Patient in Clinical Trial Evaluating CYNK-001 in COVID-19 Patients
Sept 08, 2020 | Clinical Trial
16. Co-Diagnostics Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
Sept 08, 2020 | Collaboration
14. CytoSorbents Reports the CytoSorb Therapy in COVID-19 ICU Patients (CTC) Registry Is Actively Enrolling
Sept 08, 2020 | Clinical Trial
13. Ampio Reports Enrollment Completion for IV COVID-19 Clinical Trial & Provides Update on OAK Clinical Trial
Sept 04, 2020 |Clinical Trial
12. DetectaChem Receives FDA EUA Authorization for Mobile COVID-19 Detection Technology
Sept 03, 2020 | DigiHealth
11. Sanofi And GSK Initiate P-I/II Study of COVID-19 Protein-Based Vaccine
Sept 03, 2020 | Clinical Trial
10. Experts at CenExel Clinical Research Sites Tackle COVID-19 Vaccine Testing
Sept 02, 2020 | Clinical Trial
9. ANVISA Authorizes Dompé’s REPAVID-19 P-II Study for Treatment of Severe Patients
Sept 02, 2020 | Approval
8. Sanford Health Initiates P-Ib Study of SAB-185 Against COVID-19
Sept 02, 2020 | Clinical Trial
7. Pulmonem Receives Health Canada Approval to Initiate P-III Clinical Study for COVID-19
Sept 02, 2020 | Regulatory
6. AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19
Sept 01, 2020 | Collaboration
5. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19
Sept 01, 2020 | Collaboration
4. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups
Sept 01, 2020 | Clinical Trial
3. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19
Sept 01, 2020 | Collaboration
2. Aerpio and Quantum Leap Report First Patients Dosing with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-Ill COVID-19 Patients
Sept 01, 2020 | Clinical Trial
1. Rowpar Pharmaceuticals Demonstrate CloSYS Ultra Sensitive Oral Rinse Reduced SARS-CoV-2 Infection
Sept 01, 2020 | Clinical Trial
Related News: Insights+: COVID-19 Healthcare News Monthly Updates August 2020
